Trevi (TRVI) First to Show Positive IPF Chronic Cough, RCC Data - Cantor Fitzgerald Nov 14, 2025 07:12AM
Cantor Fitzgerald Starts Trevi Therapeutics (TRVI) at Overweight Jul 1, 2025 06:48AM
Trevi Therapeutics Announces Closing of $115 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares Jun 5, 2025 04:30PM
Trevi Therapeutics (TRVI) Offering 17.4M Shares at $5.75 Jun 4, 2025 05:56AM
Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock Jun 3, 2025 10:15PM


Jun 2, 2025 04:01PM Trevi Therapeutics (TRVI) Announces Proposed $100M Share Offering
Jun 2, 2025 04:01PM Trevi Therapeutics Announces Proposed Public Offering of Common Stock
Aug 10, 2023 04:05PM Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update